Back to Agenda
Session 6: Nonclinical Studies to Support Paediatric Drug Development
Session Chair(s)
To Be Announced
, NA, Switzerland
Mette Due Theilade Thomsen, PhD
CEO, PIP Adviser ApS, Denmark
Session 6: Nonclinical Studies to Support Paediatric Drug Development
Speaker(s)
Industry Perspective
Invited Speaker
, Switzerland
ICH S11 (Nonclinical Safety Testing in Support of Development of Paediatric Medicines)
David Jones, MS
Consultant, Regulatory Pharmaco-Toxicologist, ApconiX, United Kingdom
Update on PDCO Juvenile Animal Study Projects
Karen Van Malderen
Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten , Agence Fédérale des Médicaments et des Produits de Santé, Belgium
Preclinical Disease Models for Nonclinical Pharmacology Data on Drugs
Ralph Bax, MD, PhD
Head of the Paediatric Medicines Office, European Medicines Agency, Netherlands
Industry Perspective
Andreas Hartmann, PhD
Executive Director, Novartis Pharma, Switzerland
Have an account?